Clinical Trial

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2026 (before its estimated May 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-05; most recent amendment 2026-04-20.
Trial Details
NCT Number NCT06358313
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 600 participants
Start Date 2024-04-10
Primary Completion 2026-05-10 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23